Nordex SE
Nordex SE (NDX1.DE) Financial Performance & Income Statement Overview
Analyze Nordex SE (NDX1.DE) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Nordex SE (NDX1.DE) Income Statement & Financial Overview
Review Nordex SE NDX1.DE income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.19B | $1.67B | $1.86B | $1.57B |
| Cost of Revenue | $1.69B | $1.31B | $1.71B | $1.48B |
| Gross Profit | $505.20M | $361.005M | $145.60M | $96.40M |
| Gross Profit Ratio | $0.23 | $0.22 | $0.08 | $0.06 |
| R&D Expenses | $0.00 | $0.00 | $17.93M | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $101.51M |
| Operating Expenses | $365.99M | $361.005M | $123.37M | $89.49M |
| Total Costs & Expenses | $2.05B | $1.67B | $1.84B | $1.57B |
| Interest Income | $2.40M | $6.88M | $4.10M | $4.01M |
| Interest Expense | $30.04M | $28.08M | $25.76M | $26.93M |
| Depreciation & Amortization | $46.71M | $45.47M | $43.61M | $45.21M |
| EBITDA | $109.19M | $78.41M | $69.93M | $52.13M |
| EBITDA Ratio | $0.05 | $0.05 | $0.04 | $0.03 |
| Operating Income | $139.21M | $0.00 | $22.23M | $6.91M |
| Operating Income Ratio | $0.06 | $0.00 | $0.01 | $0.004 |
| Other Income/Expenses (Net) | -$106.77M | $4.86M | -$21.66M | $107.77M |
| Income Before Tax | $32.44M | $4.86M | $573000.00 | -$16.004M |
| Income Before Tax Ratio | $0.01 | $0.003 | $0.00 | -$0.01 |
| Income Tax Expense | $14.92M | $972000.00 | $115000.00 | -$3.27M |
| Net Income | $17.39M | $3.96M | $520000.00 | -$13.04M |
| Net Income Ratio | $0.008 | $0.002 | $0.00 | -$0.008 |
| EPS | $0.08 | $0.02 | $0.002 | -$0.06 |
| Diluted EPS | $0.08 | $0.02 | $0.002 | -$0.06 |
| Weighted Avg Shares Outstanding | $227.92M | $232.20M | $236.47M | $236.45M |
| Weighted Avg Shares Outstanding (Diluted) | $227.92M | $232.19M | $236.45M | $236.45M |
Over the last four quarters, Nordex SE achieved steady financial progress, growing revenue from $1.57B in Q1 2024 to $2.19B in Q4 2024. Gross profit stayed firm with margins at 23% in Q4 2024 versus 6% in Q1 2024. Operating income totaled $139.21M in Q4 2024, maintaining a 6% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $109.19M. Net income rose to $17.39M, with EPS at $0.08. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan